NYSE:MET - MetLife Stock Price, Price Target & More

Get Started

$47.67 -0.33 (-0.69 %)

(As of 05/27/2018 01:06 AM ET)

Previous Close$47.67

Today's Range$47.3450 - $47.96

52-Week Range$43.38 - $55.91

Volume4.42 million shs

Average Volume4.86 million shs

Market Capitalization$48.79 billion

P/E Ratio10.59

Dividend Yield3.50%

Beta1.24

About MetLife (NYSE:MET)

MetLife, Inc. engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, tort settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers automobile, homeowners', and personal excess liability, as well as small business owners' property, liability, and business interruption insurance products. Further, it provides fixed annuities and pension products; medical and credit insurance products; variable, universal, term, endowment, and whole life insurance products; variable, and fixed and indexed-linked annuities; and protection against costs of long-term health care services. MetLife, Inc. has a strategic alliance with Ernst & Young LLP. The company serves individuals, corporations and their employees, and other institutions through independent agents, property and casualty specialists, sales forces, sales teams and relationship managers, and other organizations, as well as through career agency, bancassurance, direct marketing, brokerage, and other third-party distribution and e-commerce channels. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Life insurance

Sub-IndustryLife & Health Insurance

SectorFinance

SymbolNYSE:MET

CUSIP59156R10

Webwww.metlife.com

Phone212-578-9500

Debt

Debt-to-Equity Ratio0.30

Current Ratio0.15

Quick Ratio0.15

Price-To-Earnings

Trailing P/E Ratio10.59

Forward P/E Ratio9.40

P/E Growth0.83

Sales & Book Value

Annual Sales$62.09 billion

Price / Sales0.78

Cash Flow$4.4468 per share

Price / Cash10.72

Book Value$55.59 per share

Price / Book0.86

Profitability

EPS (Most Recent Fiscal Year)$4.50

Net Income$4.01 billion

Net Margins6.48%

Return on Equity8.70%

Return on Assets0.68%

Miscellaneous

Employees49,000

Outstanding Shares1,016,530,000

MetLife (NYSE:MET) Frequently Asked Questions

What is MetLife's stock symbol?

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does MetLife pay dividends? What is the dividend yield for MetLife?

MetLife declared a quarterly dividend on Tuesday, April 24th. Shareholders of record on Monday, May 7th will be paid a dividend of $0.42 per share on Wednesday, June 13th. This represents a $1.68 dividend on an annualized basis and a yield of 3.52%. The ex-dividend date of this dividend is Friday, May 4th. This is a positive change from MetLife's previous quarterly dividend of $0.40. View MetLife's Dividend History.

How will MetLife's stock buyback program work?

MetLife declared that its board has initiated a stock repurchase plan on Tuesday, May 22nd 2018, which permits the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 3.1% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's leadership believes its shares are undervalued.

How were MetLife's earnings last quarter?

MetLife (NYSE:MET) released its quarterly earnings data on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to analysts' expectations of $15.52 billion. MetLife had a return on equity of 8.70% and a net margin of 6.48%. The firm's quarterly revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.20 EPS. View MetLife's Earnings History.

What price target have analysts set for MET?

18 analysts have issued twelve-month price targets for MetLife's stock. Their predictions range from $47.00 to $78.00. On average, they anticipate MetLife's stock price to reach $57.1333 in the next twelve months. View Analyst Ratings for MetLife.

What are Wall Street analysts saying about MetLife stock?

Here are some recent quotes from research analysts about MetLife stock:

1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry in a year's time. Its efforts to streamline business, only to focus on core business, are really impressive. Its revenues grew in 2017 after declining for two years and the trend is likely to continue in 2018. Its strong international operations and disciplined capital management should drive long-term growth. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2.9% upward over the last 30 days. MetLife, Inc.’s first-quarter earnings of $1.36 per share beat the Zacks Consensus Estimate by 16.2% but declined 7% year over year. The quarter benefited from favorable underwriting, volume growth and a favorable impact of the tax reform. Nevertheless, exposure to catastrophe losses and investment in efficiency programs will put pressure on margins." (5/10/2018)
2. Wells Fargo & Co analysts commented, "We hosted investor meetings with MetLife today (March 15) at the company’s NYC headquarters. From MET were Steven Kandarian, President, Chairman & CEO; John Hele, EVP & CFO; and John Hall, SVP & Head of IR. Investors were focused on MET’s material weaknesses (MW), unit cost initiative (UCI), long term care reserves, Brighthouse exchange offer, and reinsurance opportunities with MetLife Holdings. To us, the investment case for MET remains unchanged – faster growth in less capital intensive and less volatile businesses should lower the company’s cost of equity, which in turn should allow MetLife to achieve a higher ROE spread as well as a higher valuation multiple. We reiterate our Outperform rating on MET, which is also our top pick." (3/16/2018)

Who are some of MetLife's key competitors?

Some companies that are related to MetLife include China Life Insurance (LFC), Prudential (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife (MFC), Swiss Re (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), Old Mutual (ODMTY), HANNOVER RUECK/S (HVRRY), Legal & General (LGEN), AMP (AMP), Lincoln Financial Group (LNC), AEGON (AEG) and Torchmark (TMK).

Who are MetLife's key executives?

MetLife's management team includes the folowing people:

Mr. Steven Albert Kandarian, Chairman, Pres & CEO (Age 65)
Mr. John Carroll Ramsey Hele, Exec. VP & CFO (Age 60)
Mr. Steven Jeffery Goulart, Chief Investment Officer & Exec. VP (Age 59)
Mr. Martin J. Lippert, Head of Global Technology & Operations and Exec. VP (Age 58)
Ms. Kirstie Traas, Head of Operations

Has MetLife been receiving favorable news coverage?

Media coverage about MET stock has been trending somewhat positive on Saturday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MetLife earned a media sentiment score of 0.10 on Accern's scale. They also assigned news headlines about the financial services provider an impact score of 46.82 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future.

Who are MetLife's major shareholders?

MetLife's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BOARD OF DIRECTORS OF METLIFE INC (14.90%), BOARD OF DIRECTORS OF METLIFE INC (15.00%), BlackRock Inc. (7.32%), Franklin Resources Inc. (2.47%), Massachusetts Financial Services Co. MA (2.43%) and Epoch Investment Partners Inc. (1.15%). Company insiders that own MetLife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for MetLife.

Which institutional investors are selling MetLife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., Lord Abbett & CO. LLC, Natixis, Franklin Resources Inc., Swiss National Bank, Northern Trust Corp, Thrivent Financial for Lutherans and Loomis Sayles & Co. L P. View Insider Buying and Selling for MetLife.

Which institutional investors are buying MetLife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Old Mutual Global Investors UK Ltd., Ceredex Value Advisors LLC, BlackRock Inc., Prudential Financial Inc., Epoch Investment Partners Inc., O Shaughnessy Asset Management LLC and Boston Partners. Company insiders that have bought MetLife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for MetLife.

How do I buy shares of MetLife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MetLife's stock price today?

One share of MET stock can currently be purchased for approximately $47.67.

How big of a company is MetLife?

MetLife has a market capitalization of $48.79 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. MetLife employs 49,000 workers across the globe.

How can I contact MetLife?

MetLife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

MarketBeat Community Rating for MetLife (MET)

Community Ranking:		3.2 out of 5 ( )
Outperform Votes:		683 (Vote Outperform)
Underperform Votes:		394 (Vote Underperform)
Total Votes:		1,077

MarketBeat's community ratings are surveys of what our community members think about MetLife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.

MetLife (NYSE:MET) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

18 Wall Street analysts have issued ratings and price targets for MetLife in the last 12 months. Their average twelve-month price target is $57.1333, suggesting that the stock has a possible upside of 19.85%. The high price target for MET is $78.00 and the low price target for MET is $47.00. There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.44	2.44	2.35	2.44
Ratings Breakdown:	1 Sell Rating(s) 8 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 8 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 9 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	1 Sell Rating(s) 9 Hold Rating(s) 7 Buy Rating(s) 1 Strong Buy Rating(s)
Consensus Price Target:	$57.1333	$57.60	$57.7021	$58.4879
Price Target Upside:	19.85% upside	20.98% upside	21.55% upside	10.75% upside

MetLife (NYSE:MET) Consensus Price Target History

Price Target History for MetLife (NYSE:MET)

MetLife (NYSE:MET) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/8/2018	Wells Fargo & Co	Reiterated Rating	Buy		Low
5/4/2018	Deutsche Bank	Lower Price Target	Hold ➝ Hold	$51.00 ➝ $48.00	Medium
4/25/2018	Credit Suisse Group	Initiated Coverage	Outperform ➝ Outperform	$67.00	Low
4/5/2018	Sandler O'Neill	Set Price Target	Hold	$47.00	Low
4/5/2018	Morgan Stanley	Lower Price Target	Equal Weight ➝ Equal Weight	$58.00 ➝ $56.00	Low
3/26/2018	Bank of America	Initiated Coverage	Neutral	$50.00	High
3/26/2018	Atlantic Securities	Upgrade	Neutral ➝ Overweight		High
3/2/2018	UBS	Reiterated Rating	Neutral ➝ Neutral	$52.00 ➝ $51.00	Low
2/23/2018	Keefe, Bruyette & Woods	Reiterated Rating	Buy	$56.00	Low
1/31/2018	Goldman Sachs Group	Reiterated Rating	Conviction-Buy ➝ Buy		High
11/6/2017	B. Riley	Reiterated Rating	Neutral		N/A
11/6/2017	Argus	Boost Price Target	Buy	$55.00 ➝ $60.00	N/A
11/3/2017	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$56.00 ➝ $60.00	N/A
10/10/2017	FBR & Co	Downgrade	Buy ➝ Neutral	$53.00 ➝ $52.00	N/A
8/16/2017	Langen Mcalenn	Reiterated Rating	Buy		Medium
8/11/2017	Barclays	Lower Price Target	Overweight	$67.00 ➝ $60.00	Low
7/24/2017	JPMorgan Chase & Co.	Initiated Coverage	Hold	$78.00	Low
7/7/2017	Citigroup	Set Price Target	Sell	$51.00	Low
12/9/2016	Standpoint Research	Downgrade	Buy ➝ Hold		N/A
7/6/2016	Evercore ISI	Initiated Coverage	Buy	$52.00	N/A

(Data available from 5/27/2016 forward)

MetLife (NYSE:MET) Earnings History and Estimates Chart

Earnings by Quarter for MetLife (NYSE:MET)

MetLife (NYSE:MET) Earnings Estimates

2018 EPS Consensus Estimate: $5.25
2019 EPS Consensus Estimate: $5.48

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	3	$1.10	$1.44	$1.23
Q2 2018	2	$1.13	$1.43	$1.28
Q3 2018	2	$1.25	$1.47	$1.36
Q4 2018	2	$1.33	$1.42	$1.38
Q1 2019	1	$1.36	$1.36	$1.36
Q2 2019	1	$1.28	$1.28	$1.28
Q3 2019	1	$1.38	$1.38	$1.38
Q4 2019	1	$1.46	$1.46	$1.46

MetLife (NYSE MET) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018	Q1 2018	$1.17	$1.36	$15.5168 billion	$15.1480 billion	View	Listen
2/13/2018	Q4 2017	$1.05	$0.64	$15.8867 billion	$15.7890 billion	View	N/A
11/1/2017	Q3 2017	$0.90	$1.09	$15.4685 billion	$16.1040 billion	View	N/A
8/2/2017	Q2 2017	$1.28	$1.30	$17.1129 billion	$17.3870 billion	View	Listen
5/3/2017	Q1 2017	$1.27	$1.46	$17.0216 billion	$16.2690 billion	View	Listen
2/1/2017	Q416	$1.34	$1.28	$17.34 billion	$12.0760 billion	View	Listen
11/2/2016	Q316	$1.14	$1.28	$17.03 billion	$17.70 billion	View	Listen
8/3/2016	Q216	$1.35	$0.83	$17.35 billion	$17.00 billion	View	Listen
5/4/2016	Q116	$1.38	$1.20	$17.16 billion	$16.6110 billion	View	Listen
2/3/2016	Q415	$1.36	$1.23	$17.61 billion	$17.1110 billion	View	Listen
11/4/2015	Q315	$0.76	$0.62	$17.77 billion	$17.9670 billion	View	Listen
7/29/2015	Q215	$1.47	$1.56	$17.69 billion	$17.40 billion	View	Listen
5/6/2015	Q115	$1.41	$1.44	$17.53 billion	$17.03 billion	View	Listen
2/11/2015	Q414	$1.37	$1.38	$18.18 billion	$18.25 billion	View	Listen
10/29/2014	Q314	$1.38	$1.60	$17.65 billion	$17.9180 billion	View	Listen
7/30/2014	Q214	$1.41	$1.39	$17.54 billion	$17.8010 billion	View	Listen
4/30/2014	Q114	$1.40	$1.37	$17.4991 billion	$17.1160 billion	View	Listen
2/13/2014	Q413	$1.30	$1.37	$17.43 billion	$18.3820 billion	View	Listen
10/31/2013	Q313	$1.34	$1.34	$17.23 billion	$16.90 billion	View	Listen
7/31/2013	Q2 2013	$1.33	$1.44	$17.31 billion	$17.04 billion	View	Listen
5/1/2013	Q1 2013	$1.31	$1.48	$17.3423 billion	$17.00 million	View	Listen
2/13/2013	Q4 2012	$1.18	$1.25	$17.25 billion	$18.36 billion	View	Listen
10/31/2012		$1.28	$1.32			View	N/A
8/1/2012		$1.25	$1.33			View	N/A
4/26/2012		$1.26	$1.37			View	N/A
2/14/2012		$1.25	$1.31			View	N/A
10/27/2011		$1.09	$1.11			View	N/A
7/28/2011		$1.13	$1.13			View	N/A
5/5/2011		$1.26	$1.33			View	N/A
2/9/2011		$1.10	$1.14			View	N/A
10/28/2010	Q3 2010	$1.03	$0.99			View	N/A
7/29/2010	Q2 2010	$1.00	$1.23			View	N/A
4/29/2010	Q1 2010	$0.97	$1.01			View	N/A
2/2/2010	Q4 2009	$0.95	$0.96			View	N/A
10/29/2009	Q3 2009	$0.86	$0.87			View	N/A
7/30/2009	Q2 2009	$0.70	$0.88			View	N/A
4/30/2009	Q1 2009	$0.47	$0.20			View	N/A
2/3/2009	Q4 2008	$0.14	$0.19			View	N/A
10/29/2008	Q3 2008	$0.89	$0.88			View	N/A
7/29/2008	Q2 2008	$1.51	$1.30			View	N/A
5/1/2008	Q1 2008	$1.48	$1.52			View	N/A
2/6/2008	Q4 2007	$1.43	$1.60			View	N/A

(Earnings results data provided by Zacks Investment Research)

MetLife (NYSE:MET) Dividend Information

MetLife pays an annual dividend of $1.68 per share, with a dividend yield of 3.52%. MET's next quarterly dividend payment will be made on Wednesday, June 13. The company has grown its dividend for the last 5 consecutive years and is increasing its dividend by an average of 6.50% each year. MetLife pays out 37.33% of its earnings out as a dividend.

Next Dividend:	6/13/2018
Annual Dividend:	$1.68
Dividend Yield:	3.52%
Dividend Growth:	6.50% (3 Year Average)
Payout Ratio(s):	37.33% (Trailing 12 Months of Earnings) 33.14% (Based on This Year's Estimates) 30.66% (Based on Next Year's Estimates) 37.78% (Based on Cash Flow)
Track Record:	5 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for MetLife (NYSE:MET)

MetLife (NYSE:MET) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/24/2018	quarterly	$0.42	3.53%	5/4/2018	5/7/2018	6/13/2018
1/5/2018	quarterly	$0.40	3.08%	2/2/2018	2/5/2018	3/13/2018
10/24/2017	quarterly	$0.40	2.97%	11/3/2017	11/6/2017	12/13/2017
7/7/2017	quarterly	$0.40	2.85%	8/3/2017	8/7/2017	9/13/2017
4/25/2017	quarterly	$0.40	3.08%	5/4/2017	5/8/2017	6/13/2017
1/6/2017	quarterly	$0.40	2.98%	2/2/2017	2/6/2017	3/13/2017
10/25/2016	quarterly	$0.40	3.41%	11/3/2016	11/7/2016	12/13/2016
7/7/2016	quarterly	$0.40	4.08%	8/4/2016	8/8/2016	9/13/2016
4/26/2016	quarterly	$0.40	3.42%	5/5/2016	5/9/2016	6/13/2016
10/27/2015	quarterly	$0.3750	2.93%	11/4/2015	11/6/2015	12/11/2015
7/7/2015	quarterly	$0.3750	2.76%	8/5/2015	8/7/2015	9/11/2015
4/28/2015	quarterly	$0.3750	2.88%	5/7/2015	5/11/2015	6/12/2015
1/6/2015	quarterly	$0.35	2.73%	2/4/2015	2/6/2015	3/13/2015
10/28/2014	quarterly	$0.35	2.68%	11/5/2014	11/7/2014	12/12/2014
7/7/2014	quarterly	$0.35	2.5%	8/6/2014	8/8/2014	9/12/2014
4/22/2014	quarterly	$0.35	2.7%	5/7/2014	5/9/2014	6/13/2014
1/6/2014	quarterly	$0.2750	2.06%	2/4/2014	2/6/2014	3/13/2014
10/22/2013	quarterly	$0.2750	2.28%	11/6/2013	11/8/2013	12/13/2013
6/25/2013	quarterly	$0.2750	2.42%	8/7/2013	8/9/2013	9/13/2013
4/23/2013	quarterly	$0.2750	2.87%	5/7/2013	5/9/2013	6/13/2013
1/4/2013	quarterly	$0.1850	2.07%	2/4/2013	2/6/2013	3/13/2013

(Data available from 1/1/2013 forward)

MetLife (NYSE MET) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.34%
Institutional Ownership Percentage: 77.36%

Insider Trading History for MetLife (NYSE:MET)

Institutional Ownership by Quarter for MetLife (NYSE:MET)

MetLife (NYSE MET) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/9/2018	Gerald L Hassell	Director	Buy	10,000	$46.18	$461,800.00
11/6/2017	Christopher G Townsend	Insider	Sell	55,712	$54.29	$3,024,604.48	25,181
11/3/2017	Christopher G Townsend	Insider	Sell	82,731	$54.60	$4,517,112.60	49,660
3/22/2017	James M Kilts	Director	Buy	17,205	$51.13	$879,691.65	59,443
3/1/2017	James M Kilts	Director	Buy	2,795	$54.17	$151,405.15	41,951
12/23/2016	Peter M Carlson	EVP	Sell	23,636	$54.32	$1,283,907.52	39,914
12/1/2016	Frans Hijkoop	EVP	Sell	14,997	$56.18	$842,531.46	70,560
11/9/2016	Frans Hijkoop	EVP	Sell	56,250	$51.48	$2,895,750.00	111,813
11/1/2016	Maria R Morris	EVP	Sell	2,200	$47.33	$104,126.00	109,809
10/4/2016	Maria R Morris	EVP	Sell	8,800	$45.00	$396,000.00	116,409
8/2/2016	Maria R Morris	EVP	Sell	2,000	$42.96	$85,920.00	109,273
7/1/2016	Maria R Morris	EVP	Sell	2,000	$39.43	$78,860.00	109,273
6/1/2016	Maria R Morris	EVP	Sell	4,200	$45.15	$189,630.00	108,932
5/2/2016	Maria R Morris	EVP	Sell	4,200	$45.46	$190,932.00	108,932
4/18/2016	Maria R Morris	EVP	Sell	2,200	$45.00	$99,000.00	109,132
3/30/2016	Maria R Morris	EVP	Sell	4,400	$45.00	$198,000.00	111,332
3/1/2016	Maria R Morris	EVP	Sell	2,000	$39.97	$79,940.00	108,623
2/1/2016	Maria R. Morris	EVP	Sell	2,000	$44.31	$88,620.00	89,562
12/2/2015	Kenton J Sicchitano	Director	Sell	9,503	$50.78	$482,562.34	26,947
12/1/2015	Maria R. Morris	EVP	Sell	4,200	$51.23	$215,166.00	89,275
11/2/2015	Maria R. Morris	EVP	Sell	4,200	$50.60	$212,520.00	89,275
10/1/2015	Maria R. Morris	EVP	Sell	4,200	$47.22	$198,324.00	89,275
9/1/2015	Maria R. Morris	EVP	Sell	4,200	$48.42	$203,364.00	89,000
7/1/2015	Maria R Morris	EVP	Sell	6,200	$57.00	$353,400.00
6/22/2015	Steven A Kandarian	CEO	Sell	17,500	$57.12	$999,600.00
6/2/2015	Maria R Morris	EVP	Sell	6,200	$52.41	$324,942.00
5/1/2015	Maria R Morris	EVP	Sell	4,200	$51.72	$217,224.00
4/1/2015	Maria R Morris	EVP	Sell	4,200	$50.24	$211,008.00
3/6/2015	Maria R Morris	EVP	Sell	2,000	$53.00	$106,000.00
3/2/2015	Maria R Morris	EVP	Sell	4,200	$50.63	$212,646.00
2/2/2015	Maria R Morris	EVP	Sell	4,200	$46.85	$196,770.00
1/2/2015	Maria R Morris	EVP	Sell	4,200	$54.58	$229,236.00
10/28/2014	Maria R Morris	EVP	Sell	18,300	$51.74	$946,842.00
6/12/2014	Peter M Carlson	CAO	Sell	91,625	$54.29	$4,974,321.25
3/6/2014	Beth Hirschhorn	EVP	Sell	30,594	$52.44	$1,604,349.36	34,216
12/24/2013	Maria Morris	EVP	Sell	12,000	$53.08	$636,960.00	65,844
8/14/2013	John Keane	Director	Sell	1,210	$49.57	$59,979.70	29,957
8/5/2013	William Wheeler	Insider	Sell	40,000	$50.92	$2,036,800.00	230,867
5/29/2013	Beth Hirschhorn	EVP	Sell	20,764	$44.18	$917,353.52
5/8/2013	Kenton J Sicchitano	Director	Sell	1,536	$40.77	$62,622.72

(Data available from 1/1/2013 forward)

MetLife (NYSE MET) News Headlines

Source:

Date	Headline
	Stock Repurchase Plan Authorized by MetLife (MET) Board of Directors www.americanbankingnews.com - May 25 at 1:16 AM
	MetLife's Approves Share Buyback, Boosts Shareholders' Value www.zacks.com - May 23 at 5:45 PM
	BRIEF-MetLife Announces New $1.5 Bln Share Repurchase Authorization www.reuters.com - May 22 at 5:15 PM
	MetLife's board approves $1.5 billion share buyback program finance.yahoo.com - May 22 at 5:15 PM
	MetLife Announces New $1.5 Billion Share Repurchase Authorization finance.yahoo.com - May 22 at 5:15 PM
	Is MetLife Inc (NYSE:MET) Worth $48.09 Based On Intrinsic Value? finance.yahoo.com - May 22 at 5:15 PM
	Free Technical Reports on MetLife and Three Additional Insurance Equities finance.yahoo.com - May 22 at 8:10 AM
	BRIEF-Metlife Investment Management Says Facebook Signed Long-Term Lease For All Of Park Tower At Transbay www.reuters.com - May 21 at 5:17 PM
	MetLife Investment Management, The John Buck Company and Golub & Company Announce Facebook Lease of Park ... www.businesswire.com - May 21 at 5:17 PM
	MetLife: Profitability Is Set To Improve seekingalpha.com - May 21 at 5:17 PM
	MetLife Investment Management, The John Buck Company and Golub & Company Announce Facebook Lease of Park Tower in San Francisco finance.yahoo.com - May 21 at 5:17 PM
	MetLife Foundation Partners with Kiva to Support Entrepreneurs and Build Financial Inclusion finance.yahoo.com - May 21 at 8:07 AM
	Financial Analysis: Atlantic American (AAME) versus MetLife (MET) www.americanbankingnews.com - May 18 at 7:33 PM
	MetLife names Bill O'Donnell as US CFO www.reuters.com - May 17 at 8:10 AM
	MetLife's insurance plan covers diabetic's amputation after a car crash - 9th Circuit www.reuters.com - May 17 at 8:10 AM
	CFO Moves: Houzz, MetLife, SEC blogs.wsj.com - May 17 at 8:10 AM
	BRIEF-MetLife Names Bill O'Donnell As US CFO www.reuters.com - May 16 at 5:56 PM
	MetLife Launches PlanSmart www.businesswire.com - May 16 at 5:56 PM
	MetLife names Bill O'Donnell as U.S. CFO finance.yahoo.com - May 16 at 5:56 PM
	MetLife Names Bill O’Donnell as U.S. Chief Financial Officer finance.yahoo.com - May 16 at 5:56 PM
	MetLife Launches PlanSmart® Financial Wellness finance.yahoo.com - May 16 at 5:56 PM
	Goldman Sachs & Co. LLC, JP Morgan Securities LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC ... www.prnewswire.com - May 15 at 5:56 PM
	MetLife Declares Second Quarter 2018 Preferred Stock Dividends finance.yahoo.com - May 15 at 5:56 PM
	MetLife: Why I Am Staying The Course With This 'Troubled' Insurer seekingalpha.com - May 15 at 8:13 AM
	MetLife (MET) Receives Average Rating of "Hold" from Brokerages www.americanbankingnews.com - May 15 at 1:38 AM
	Analyzing Prudential’s Life Planner Division’s Performance finance.yahoo.com - May 14 at 8:11 AM
	Apon Wellbeing Ltd. wins MetLife Foundation Financial Innovation Competition powered by Verb, secures $50,000 Grant www.prnewswire.com - May 12 at 11:27 PM
	WSJ Wealth Adviser Briefing: CEO Pay, MetLife Pensions, Overworked Parents blogs.wsj.com - May 11 at 8:06 AM
	MetLife (MET) Director Gerald L. Hassell Acquires 10,000 Shares www.americanbankingnews.com - May 10 at 7:35 PM
	Zacks Investment Research Upgrades MetLife (MET) to "Buy" www.americanbankingnews.com - May 10 at 1:02 PM
	MetLife selects eight finalists for open innovation programme, collab 3.0 EMEA finance.yahoo.com - May 10 at 8:09 AM
	Is MetLife Inc (NYSE:MET) Undervalued? finance.yahoo.com - May 10 at 8:09 AM
	FY2018 Earnings Forecast for MetLife (MET) Issued By Langen Mcalenn www.americanbankingnews.com - May 10 at 8:02 AM
	MetLife unveils design of its new 'Midtown Union' project www.bizjournals.com - May 9 at 5:48 PM
	MetLife (MET) Earns "Buy" Rating from Wells Fargo www.americanbankingnews.com - May 9 at 12:08 PM
	Research Analysts Offer Predictions for MetLife's Q2 2018 Earnings (MET) www.americanbankingnews.com - May 9 at 8:41 AM
	MetLife to Post FY2018 Earnings of $5.00 Per Share, B. Riley Forecasts (MET) www.americanbankingnews.com - May 9 at 8:32 AM
	BRIEF-MetLife To Provide Pension Benefits To Approximately 41000 Fedex Retirees And Beneficiaries www.reuters.com - May 9 at 8:06 AM
	MetLife Will Take Over Pensions for 41000 FedEx Retirees www.wsj.com - May 9 at 8:06 AM
	MetLife to Provide Pension Benefits to Approximately 41000 FedEx Retirees and Beneficiaries www.businesswire.com - May 9 at 8:06 AM
	MetLife to provide pension benefits to 41,000 FedEx retirees through annuity finance.yahoo.com - May 8 at 5:52 PM
	MetLife to Provide Pension Benefits to Approximately 41,000 FedEx Retirees and Beneficiaries finance.yahoo.com - May 8 at 5:52 PM
	FedEx to Transfer $6 Billion in Pension Obligations to MetLife finance.yahoo.com - May 8 at 5:52 PM
	B. Riley Analysts Lift Earnings Estimates for MetLife (MET) www.americanbankingnews.com - May 8 at 6:43 AM
	MetLife (MET) versus Reinsurance Group of America (RGA) Financial Analysis www.americanbankingnews.com - May 7 at 11:24 AM
	MetLife (MET) Expected to Post Q2 2018 Earnings of $1.16 Per Share www.americanbankingnews.com - May 7 at 1:56 AM
	MetLife (MET) Stock Rating Reaffirmed by Deutsche Bank www.americanbankingnews.com - May 5 at 12:55 AM
	Key Takeaways And Trends From MetLife's Q1 Results www.nasdaq.com - May 4 at 5:45 PM
	General American Life Insurance Company -- Moody's withdraws General American Life's Aa3 financial strength rating on merger into Metropolitan Tower Life finance.yahoo.com - May 4 at 5:45 PM
	Q3 2019 Earnings Estimate for MetLife Issued By Langen Mcalenn (MET) www.americanbankingnews.com - May 4 at 10:19 AM

MetLife (NYSE:MET) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

MetLife (NYSE:MET) Income Statement, Balance Sheet and Cash Flow Statement

MetLife (NYSE MET) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff